← back to search

Simone Mocellin

University of Padua · IT
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Medicine, Melanoma, Oncology, Internal medicine, Meta-analysis, and Breast cancer.
h-index
citations
4,953
works
60
NIH funding
primary concept
email

Recent publications

Molecular Basis of BRAF Inhibitor Resistance in Melanoma: A Systematic Review
Pharmaceuticals 2025cited by 11position: middledoi
1613P NEO-TIM: Predictive biomarkers and long-term outcomes in the NEO-TIM trial of neoadjuvant immunotherapy and targeted therapy in melanoma
Annals of Oncology 2025cited by 0position: middledoi
Kaposi’s Sarcoma: Evaluation of Clinical Features, Treatment Outcomes, and Prognosis in a Single-Center Retrospective Case Series
Cancers 2024cited by 14position: middledoi
Alpha-melanocyte stimulating hormone (α-MSH): biology, clinical relevance and implication in melanoma
Journal of Translational Medicine 2023cited by 48position: lastdoi
Gender Differences in Soft Tissue and Bone Sarcoma: A Narrative Review
Cancers 2023cited by 22position: middledoi
Sex Differences in Cutaneous Melanoma: Incidence, Clinicopathological Profile, Survival, and Costs
Journal of Women s Health 2022cited by 35position: lastdoi
Cutaneous Melanoma and Hormones: Focus on Sex Differences and the Testis
International Journal of Molecular Sciences 2022cited by 22position: middledoi
Prognosis for Cutaneous Melanoma by Clinical and Pathological Profile: A Population-Based Study
Frontiers in Oncology 2021cited by 29position: middledoi
The Molecular Landscape of Primary Acral Melanoma: A Multicenter Study of the Italian Melanoma Intergroup (IMI)
International Journal of Molecular Sciences 2021cited by 22position: middledoi
Spermatic Cord Sarcoma: A 20-Year Single-Institution Experience
Frontiers in Surgery 2020cited by 22position: lastdoi
Gold Nanoparticle Aggregates Functionalized with Cyclic RGD Peptides for Targeting and Imaging of Colorectal Cancer Cells
ACS Applied Nano Materials 2019cited by 50position: middledoi
New paradigm for stage III melanoma: from surgery to adjuvant treatment
Journal of Translational Medicine 2019cited by 41position: middledoi
Risk-reducing medications for primary breast cancer: a network meta-analysis
Cochrane Database of Systematic Reviews 2019cited by 29position: firstdoi
Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade
Journal of Translational Medicine 2018cited by 198position: middledoi
Electrochemotherapy – Emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration
European Journal of Surgical Oncology 2018cited by 179position: middledoi
Circadian pathway genetic variation and cancer risk: evidence from genome-wide association studies
BMC Medicine 2018cited by 109position: firstdoi
<i>BRAF</i> Gene Copy Number and Mutant Allele Frequency Correlate with Time to Progression in Metastatic Melanoma Patients Treated with MAPK Inhibitors
Molecular Cancer Therapeutics 2018cited by 35position: middledoi
Associations of clock genes polymorphisms with soft tissue sarcoma susceptibility and prognosis
Journal of Translational Medicine 2018cited by 28position: lastdoi
Prototyping a precision oncology 3.0 rapid learning platform
BMC Bioinformatics 2018cited by 7position: middledoi
Pancreaticojejunostomy versus pancreaticogastrostomy reconstruction for the prevention of postoperative pancreatic fistula following pancreaticoduodenectomy
Cochrane Database of Systematic Reviews 2017cited by 131position: lastdoi
Genetic variation of clock genes and cancer risk: a field synopsis and meta-analysis
Oncotarget 2017cited by 70position: lastdoi
Immune checkpoint inhibitors and targeted therapies for metastatic melanoma: A network meta-analysis
Cancer Treatment Reviews 2017cited by 61position: lastdoi
Basal cell carcinoma: 10-year experience with electrochemotherapy
Journal of Translational Medicine 2017cited by 61position: lastdoi
Enhanced EGFR Targeting Activity of Plasmonic Nanostructures with Engineered GE11 Peptide
Advanced Healthcare Materials 2017cited by 55position: middledoi
Prediction of Non-sentinel Node Status in Patients with Melanoma and Positive Sentinel Node Biopsy: An Italian Melanoma Intergroup (IMI) Study
Annals of Surgical Oncology 2017cited by 50position: middledoi
Second-line systemic therapy for metastatic colorectal cancer
Cochrane Database of Systematic Reviews 2017cited by 48position: firstdoi
Prototyping a precision oncology 3.0 rapid learning platform
DSpace@MIT (Massachusetts Institute of Technology) 2017cited by 0position: middle
Effect of BRCA germline mutations on breast cancer prognosis
Medicine 2016cited by 266position: middledoi
Treatment efficacy with electrochemotherapy: A multi-institutional prospective observational study on 376 patients with superficial tumors
European Journal of Surgical Oncology 2016cited by 118position: middledoi
Vitamin B6 and Cancer Risk: A Field Synopsis and Meta-Analysis
JNCI Journal of the National Cancer Institute 2016cited by 110position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Carlo Riccardo Rossi · University of Padua16 papers (2012–2022)Donato Nitti · University of Padua13 papers (2012–2017)Pierluigi Pilati · University of Padua11 papers (2012–2017)L Campana · University of Padua10 papers (2012–2018) · 9 papers (2018–2025)Sandro Pasquali · University of Padua9 papers (2013–2019)Sara Valpione · University of Manchester8 papers (2012–2018)Clara Benna · University of Padua8 papers (2012–2022)Vanna Chiarion‐Sileni · Istituto Oncologico Veneto7 papers (2012–2018) · 5 papers (2013–2025)Jacopo Pigozzo · Istituto Oncologico Veneto5 papers (2015–2025) · 5 papers (2013–2019)Pietro Quaglino · Austrian Society of Dermatology and Venereology5 papers (2013–2019)Simone Ribero · Department of Medical Sciences4 papers (2013–2021)Senthilkumar Rajendran · University of Padua4 papers (2017–2019) · 3 papers (2013–2017) · 3 papers (2018–2025) · 3 papers (2013–2016)Ilaria Cosci · University of Padua3 papers (2022–2025)Massimo Rugge · Fondazione Progetto Ematologia3 papers (2013–2022)